April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Critical Role of TNF in Diabetic Retinal Microvascular Damage Mediated Through Rock Pathway
Author Affiliations & Notes
  • R. Arita
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • Y. Hata
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • T. Kita
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • S. Kawahara
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • S. Nakao
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • T. Ishibashi
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • Footnotes
    Commercial Relationships  R. Arita, None; Y. Hata, None; T. Kita, None; S. Kawahara, None; S. Nakao, None; T. Ishibashi, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4977. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. Arita, Y. Hata, T. Kita, S. Kawahara, S. Nakao, T. Ishibashi; Critical Role of TNF in Diabetic Retinal Microvascular Damage Mediated Through Rock Pathway. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4977.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Inflammation is thought to play an important role in the pathogeneses of diabetic retinopathy. Particularly, the involvement of a pro-inflammatory cytokine tumor neorosis facter (TNF)-a has been indicated. However, its precise mechanisms are not fully understood. We previously revealed the importance of Rho/Rho-kinase (ROCK) pathway in adherent leukocytes-induced diabetic microvascular damage. We herein investigated the involvement of TNF- in diabetic retinal microvascular damage mediated through Rho/ROCK pathway.

Methods: : In cultured human microvascular endothelial cells and neutrophils isolated from human peripheral blood, we investigated phosphorylation of MYPT-1, a downstream mediator of ROCK, and the surface expression of CD11b/CD18 on neutrophils in the presence of recombinant TNF- or serum from diabetic retinopathy (DR) patients with or without fasudil (ROCK inhibitor), SB203580 (p38MAPK inhibitor) or PD98059 (MEK1 inhibitor) by western blotting and flow cytometry. Moreover, in co-culture system of these cells, we investigated the effects of TNF- neutralizing antibody by measuring the number of adherent neutrophils and TUNEL-positive endothelial cells. In vivo, we investigated the effect of soluble TNF- receptor (sTNFR: 500 µg/kg subcutaneously 3 times a week for a month) on MYPT-1 phosphorylation, CD11b/18 expression on neutrophils, leukocyte adhesion and endothelial damage in diabetic rats’ retinal tissue.

Results: : In vitro, TNF- and serum from DR patients promoted MYPT-1 phosphorylation in endothelial cells and neutrophils. TNF- also increased the expression of CD11b/18 on neutrophils. In addition, fasudil completely and PD98059 partially suppressed TNF-a induced MYPT-1 phosphorylation and CD11b/18 expression on neutrophils. TNF- neutralizing antibody significantly suppressed serum induced MYPT-1 phosphorylation and decreased the number of adherent neutrophils and TUNEL-positive endothelial cells in co-culture system.In vivo, sTNFR similarly suppressed diabetes-induced MYPT-1 phosphorylation in neutrophils and retinal tissue, CD11b/18 expression on neutrophils, leukocyte adhesion and endothelial damage.

Conclusions: : These data suggest that TNF- has a potential to activate ROCK pathway in diabetic retinal microvascular system through p44/42MAPK at least in part, and cause diabetic microvascular damage. TNF- blockade could be a novel target for the prevention of diabetic retinopathy in its early phase.

Keywords: diabetes • diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×